Work

Prospects and Challenges in Defining Risk-reducing Medications for the Prevention of BRCA1/2-associated Breast Cancer

Year: 2026

Type: article

Source: Cancer Prevention Research

DOI: 10.1158/1940-6207.capr-26-0128

Authors: Felicity C. Martin, Geoffrey J. Lindeman

Institution: Walter and Eliza Hall Institute of Medical Research

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7224191622

FWCI:

Cites:

Cited by:

Related to: 10